Hasil Pencarian - Michael Matthias Ackerl

  • Menampilkan 1 - 1 hasil dari 1
Perbaiki Hasil
  1. 1
    Favorable benefit–risk ratio with teriflunomide treatment in relapsing-remitting multiple sclerosis: Results of the 2-year, multicenter, prospective, noninterventional TAURUS MS study in Austria

    Favorable benefit–risk ratio with teriflunomide treatment in relapsing-remitting multiple sclerosis: Results of the 2-year, multicenter, prospective, noninterventional TAURUS MS st... oleh Michael Guger, Michael Matthias Ackerl, Martin Heine, Christiane Hofinger-Renner, Heinrich Karl Spiss, Andrea Taut, Karin Unger, Fritz Leutmezer

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: